No Data
No Data
Shandong Pharmaceutical Glass (600529.SH) options rights distribution: 0.3 yuan per share.
shandong pharmaceutical glass (600529.SH) announced that the company will implement the mid-term equity distribution plan in 2024...
Shandong Pharmaceutical Glass Co.Ltd's (SHSE:600529) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
CICC: Cement demand is expected to marginally improve, while the supply and demand of float glass still needs to be rebalanced.
Due to the slow recovery of infrastructure physical workload and real estate demand, as well as the emphasis on business quality in the operation strategy of construction and building material enterprises, the corresponding performance is reflected in the refusal of bridge financing and the intensified competition for high-quality projects, resulting in overall pressure on the income and profit of construction and building material enterprises in 2Q24.
Shandong Pharmaceutical Glass' H1 Profit Jumps 23%, Operating Income Up 7%; Shares Soar 10%
Shandong Pharmaceutical Glass Co., Ltd.'s semi-annual report for 2024.
Summary of the semi-annual report of Shandong Pharmaceutical Glass Co., Ltd. in 2024.
No Data
No Data